GLI1 and ovarian cancer: Furthermore, the authors showed that the expression levels of SMO and Gli1 in cancer tissues from patients with cisplatin-resistant ovarian cancer were significantly higher than those from patients with cisplatin-sensitive ovarian cancer, suggesting that the activation of hedgehog signaling is important for malignant transformation and chemotherapy resistance [54].